ask="16.90"
ask_size="100"
average_daily_volume="160051"
bid="15.43"
bid_size="100"
book_value="-91.82"
change="+0.00"
change_from_200_day_moving_average="2.18"
change_from_50_day_moving_average="1.47"
change_from_52_week_high="-0.49"
change_From_52_week_low="4.11"
change_in_percent="+0.00%"
close="16.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-41.42"
ebitda="-20.24M"
eps_estimate_current_year="-2.50"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.93"
ex_dividend_date="N/A"
float_shares="8856000"
high="16.65"
high_52_weeks="16.65"
last_trade_date="1/25/2017"
last_trade_price="16.16"
last_trade_size="1440"
last_trade_time="4:00pm"
low="15.77"
low_52_weeks="12.05"
market_capitalization="364.34M"
moving_average_200_day="13.98"
moving_average_50_day="14.69"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.50"
open="16.16"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+15.59%"
percent_change_from_50_day_moving_average="+10.02%"
percent_change_from_52_week_high="-2.94%"
percent_change_from_52_week_low="+34.10%"
previous_close="16.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="63.38"
revenue="5.75M"
shares_outstanding="22546000"
short_ratio="2.66"
stock_exchange="NGM"
symbol="RARX"
volume="96964"
weeks_range_52="12.05 - 16.65"
